It is true that current drugs are not doing too well by themselves. It is also true that we need to look at cancer as a multigene syndrome. But it is also essential to try and understand the mechanism. Genomics is an important tool for that purpose. Even if we have the best diagnostic tools available for early detection of tumors, not all of them can be removed so we still need to address it pharmacologically. I think that going publicly against the Cancer Genome Project is counterproductive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.